Macrae Sandy Insider Trades

Insider Trading History

Track insider trading activity for Macrae Sandy. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $139k 1,895,043 shares
Last Trade
May 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.14k 12,613 shares
$0.17
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $183k 2,500,000 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$650k 2,500,000 shares
$0.26
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $139k 1,907,656 shares
Last Trade
Feb 25, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.8k 33,637 shares
$0.47
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $142k 1,941,293 shares
Last Trade
Feb 24, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.49k 5,291 shares
$0.47
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $142k 1,946,584 shares
Last Trade
Jan 22, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$41.2k 102,950 shares
$0.40
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $150k 2,049,534 shares
Last Trade
Nov 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.14k 7,488 shares
$0.42
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $150k 2,057,022 shares
Last Trade
Oct 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$83.8k 126,950 shares
$0.66
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $160k 2,183,972 shares
Last Trade
Aug 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.42k 7,488 shares
$0.59
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $160k 2,191,460 shares
Last Trade
Jul 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$60.9k 126,950 shares
$0.48
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $169k 2,318,410 shares
Last Trade
May 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.52k 7,488 shares
$0.47
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $170k 2,325,898 shares
Last Trade
Apr 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$99k 126,950 shares
$0.78
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $152k 2,077,848 shares
Last Trade
Feb 25, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$10.2k 10,663 shares
$0.96
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $179k 2,452,848 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.68M 1,750,000 shares
$0.96
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $153k 2,088,511 shares
Last Trade
Feb 24, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$7.49k 7,488 shares
$1.00
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $153k 2,095,999 shares
Last Trade
Jan 22, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$474k 412,584 shares
$1.15
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $183k 2,508,583 shares
Last Trade
Nov 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.6k 10,642 shares
$1.94
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $184k 2,519,225 shares
Last Trade
Nov 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14k 7,473 shares
$1.88
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $185k 2,526,698 shares
Last Trade
Aug 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$6.44k 7,492 shares
$0.86
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $185k 2,534,190 shares
Last Trade
Aug 24, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.52k 5,261 shares
$0.86
$0.07
Sangamo Therapeutics
Sangamo Therapeutics SGMO
President, CEO AND DIRECTOR
Holding Value $186k 2,539,451 shares
Last Trade
May 25, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$4.5k 7,492 shares
$0.60
$0.07

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up